Tenaya Therapeutics, Inc. Shareholders' Equity
Tenaya Therapeutics, Inc. (TNYA) had Shareholders' Equity of $69.41 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $69.41M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $106.19M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $123.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $82.87M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $69.41M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $106.19M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $123.27M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $82.87M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $99.83M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $119.40M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $92.85M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $112.60M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $134.00M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $158.18M 10-Q · filed 2025-11-10 |
| 2023-12-31 | $139.42M 10-K · filed 2026-03-11 |
| 2023-09-30 | $164.88M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $189.94M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $215.41M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $243.38M 10-K · filed 2025-03-10 |
| 2022-09-30 | $196.33M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $223.87M 10-Q · filed 2023-11-08 |
| 2022-03-31 | $249.10M 10-Q · filed 2023-11-08 |
| 2021-12-31 | $278.53M 10-K · filed 2024-03-18 |
| 2021-09-30 | $303.70M 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$108.54M 10-Q · filed 2022-11-10 |
| 2021-03-31 | -$93.94M 10-Q · filed 2022-11-10 |
| 2020-12-31 | -$81.31M 10-K · filed 2023-03-08 |
| 2020-09-30 | -$71.23M 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$61.15M 10-Q · filed 2021-11-10 |
| 2020-03-31 | -$52.62M 10-Q · filed 2021-11-10 |
| 2019-12-31 | -$43.74M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |